
pmid: 28866374
Bcl-2 proteins, such as B-cell lymphoma (Bcl-2) protein, myeloid cell leukemia sequence 1 (Mcl-1) protein, has been implicated in the progression and survival of multiple tumor types and become a validated and attractive target for cancer therapy. In this work, a series of 1-phenyl-1H-indole derivatives has been designed and synthesized. The preliminary biological studies (binding assay for Bcl-2 proteins and MTT assay) suggested that some active compounds showed potent inhibitory activities on Bcl-2/Mcl-1 without binding on Bcl-XL. Furthermore, Compound 9c and 9h showed better anti-proliferative activity than WL-276.
Indoles, Dose-Response Relationship, Drug, Molecular Structure, Antineoplastic Agents, Molecular Docking Simulation, Structure-Activity Relationship, Proto-Oncogene Proteins c-bcl-2, Cell Line, Tumor, Drug Design, Humans, Myeloid Cell Leukemia Sequence 1 Protein, Drug Screening Assays, Antitumor, Cell Proliferation
Indoles, Dose-Response Relationship, Drug, Molecular Structure, Antineoplastic Agents, Molecular Docking Simulation, Structure-Activity Relationship, Proto-Oncogene Proteins c-bcl-2, Cell Line, Tumor, Drug Design, Humans, Myeloid Cell Leukemia Sequence 1 Protein, Drug Screening Assays, Antitumor, Cell Proliferation
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 28 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
